Replies to post #141957 on Biotech Values

[genisi]

Any reason why this would be specific to type 1 diabetes vs other autoimmune conditions?

DiaPep277 was detected as a target of a diabetogenic T-cell clone derived from mice model for type 1 diabetes (NOD) and Prof. Cohen focused on diabetes since. No reason as far as my understanding goes, that the parent molecule of the peptide—HSP60 wouldn't work in other autoimmune and inflammatory conditions see

http://www.ncbi.nlm.nih.gov/pubmed/18575269

Might not produce dramatic results, but much less likely to produce serious side effects a la Tysabri

Exactly what data suggest for DiaPep277 so far.